Bionano Genomics, Inc. (BNGO) Financials

BNGO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 64.8 million 27.3 million
Dec. 31, 2025 73.6 million 29.2 million
Sept. 30, 2025 79.1 million 29.3 million
June 30, 2025 76.0 million 30.6 million

BNGO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -5.7 million 670000
Dec. 31, 2025 -4.2 million 926000
Sept. 30, 2025 -5.9 million 941000
June 30, 2025 -3.5 million 1.1 million

BNGO Net Income

No data available :(

BNGO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 24.7 million - 6.0 million
Dec. 31, 2025 13.3 million 6.0 million 6.9 million
Sept. 30, 2025 3.1 million 6.1 million 7.4 million
June 30, 2025 16.4 million - 7.8 million

BNGO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 5.4 million
Dec. 31, 2025 5.4 million
Sept. 30, 2025 5.3 million
June 30, 2025 3.4 million

BNGO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 3.1 million 8.0 million -
Dec. 31, 2025 - 3.2 million 8.7 million -
Sept. 30, 2025 - 2.8 million 9.1 million -
June 30, 2025 - 2.9 million 8.3 million -

BNGO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 6.7 million 3.4 million
Dec. 31, 2025 8.0 million 4.6 million
Sept. 30, 2025 7.4 million 4.0 million
June 30, 2025 6.7 million 3.3 million

BNGO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BNGO

Price: $1.12

52 week price:
1.06
5.50

Earnings Per Share: -4.46 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 6.9 million

Market Capitalization: 13.3 million

Links: